BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,163,497 | -20.6% | 23,168 | -0.1% | 0.15% | -27.2% |
| Q2 2023 | $1,465,861 | +40.5% | 23,194 | +0.0% | 0.20% | +43.3% |
| Q1 2023 | $1,043,093 | -18.2% | 23,185 | -20.4% | 0.14% | -31.9% |
| Q4 2022 | $1,275,660 | +7.8% | 29,118 | +62.2% | 0.21% | +15.6% |
| Q3 2022 | $1,183,000 | +378.9% | 17,948 | +363.3% | 0.18% | +752.4% |
| Q1 2022 | $247,000 | -94.5% | 3,874 | -91.6% | 0.02% | -93.5% |
| Q1 2021 | $4,473,000 | -27.4% | 46,000 | -16.2% | 0.32% | -22.8% |
| Q4 2020 | $6,159,000 | +3.0% | 54,918 | -14.9% | 0.42% | +5.3% |
| Q3 2020 | $5,979,000 | +11.1% | 64,500 | -6.6% | 0.40% | +7.9% |
| Q2 2020 | $5,384,000 | -3.7% | 69,031 | -27.8% | 0.37% | -17.4% |
| Q1 2020 | $5,592,000 | +14.4% | 95,627 | +56.8% | 0.44% | +47.2% |
| Q4 2019 | $4,887,000 | +15.3% | 61,000 | +5.7% | 0.30% | +19.4% |
| Q3 2019 | $4,239,000 | -22.1% | 57,700 | +0.1% | 0.25% | -21.5% |
| Q2 2019 | $5,439,000 | – | 57,660 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |